Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

Intravenous brivaracetam in status epilepticus: Correlation between loading dose, plasma levels and clinical response.

Aicua-Rapun I, André P, Rossetti AO, Decosterd LA, Buclin T, Novy J.

Epilepsy Res. 2018 Dec 3;149:88-91. doi: 10.1016/j.eplepsyres.2018.12.001. [Epub ahead of print]

PMID:
30530123
2.

Multicenter population pharmacokinetic study of colistimethate sodium and colistin dosed as in normal renal function in patients on continuous renal replacement therapy.

Leuppi-Taegtmeyer AB, Decosterd L, Osthoff M, Mueller NJ, Buclin T, Corti N.

Antimicrob Agents Chemother. 2018 Nov 26. pii: AAC.01957-18. doi: 10.1128/AAC.01957-18. [Epub ahead of print]

PMID:
30478168
3.

Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections.

Burger R, Guidi M, Calpini V, Lamoth F, Decosterd L, Robatel C, Buclin T, Csajka C, Marchetti O.

J Antimicrob Chemother. 2018 Dec 1;73(12):3413-3422. doi: 10.1093/jac/dky370.

PMID:
30304491
4.

Levetiracetam circulating concentrations and response in status epilepticus.

Perrenoud M, André P, Buclin T, Decosterd LA, Rossetti AO, Novy J.

Epilepsy Behav. 2018 Nov;88:61-65. doi: 10.1016/j.yebeh.2018.08.026. Epub 2018 Sep 18.

PMID:
30241055
5.

Myoglobinuria in two patients with Duchenne muscular dystrophy after treatment with zoledronate: a case-report and call for caution.

Ivanyuk A, García Segarra N, Buclin T, Klein A, Jacquier D, Newman CJ, Bloetzer C.

Neuromuscul Disord. 2018 Oct;28(10):865-867. doi: 10.1016/j.nmd.2018.08.004. Epub 2018 Aug 10.

PMID:
30217487
6.

Comparison against current standards of a DNA aptamer for the label-free quantification of tobramycin in human sera employed for therapeutic drug monitoring.

Tenaglia E, Ferretti A, Decosterd LA, Werner D, Mercier T, Widmer N, Buclin T, Guiducci C.

J Pharm Biomed Anal. 2018 Sep 10;159:341-347. doi: 10.1016/j.jpba.2018.06.061. Epub 2018 Jun 30.

PMID:
30025299
7.

Efficacy and safety of continuous infusions with elastomeric pumps for outpatient parenteral antimicrobial therapy (OPAT): an observational study.

Voumard R, Gardiol C, André P, Arensdorff L, Cochet C, Boillat-Blanco N, Decosterd L, Buclin T, de Vallière S.

J Antimicrob Chemother. 2018 Sep 1;73(9):2540-2545. doi: 10.1093/jac/dky224.

PMID:
29982449
8.

Ethical approval for multicenter cohort studies on drug exposure during pregnancy: A survey among members of the European Network of Teratology Information Services (ENTIS).

Winterfeld U, Weber-Schöndorfer C, Schaefer C, von Elm E, Buclin T.

Reprod Toxicol. 2018 Sep;80:68-72. doi: 10.1016/j.reprotox.2018.06.002. Epub 2018 Jun 18.

PMID:
29913205
9.

Association of Patient Sex With Chemotherapy-Related Toxic Effects: A Retrospective Analysis of the PETACC-3 Trial Conducted by the EORTC Gastrointestinal Group.

Cristina V, Mahachie J, Mauer M, Buclin T, Van Cutsem E, Roth A, Wagner AD.

JAMA Oncol. 2018 Jul 1;4(7):1003-1006. doi: 10.1001/jamaoncol.2018.1080. No abstract available.

PMID:
29800044
10.

Sensitive quantification of the somatostatin analog AP102 in plasma by ultra-high pressure liquid chromatography-tandem mass spectrometry and application to a pharmacokinetic study in rats.

Eugster PJ, Boyle CN, Prod'hom S, Tarasco E, Buclin T, Lutz TA, Harris AG, Grouzmann E.

Drug Test Anal. 2018 Sep;10(9):1448-1457. doi: 10.1002/dta.2400. Epub 2018 May 29.

PMID:
29745052
11.

LC-MS/MS method for the simultaneous analysis of seven antimalarials and two active metabolites in dried blood spots for applications in field trials: Analytical and clinical validation.

Gallay J, Prod'hom S, Mercier T, Bardinet C, Spaggiari D, Pothin E, Buclin T, Genton B, Decosterd LA.

J Pharm Biomed Anal. 2018 May 30;154:263-277. doi: 10.1016/j.jpba.2018.01.017. Epub 2018 Feb 3.

PMID:
29579633
12.

Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.

Cardoso E, Mercier T, Wagner AD, Homicsko K, Michielin O, Ellefsen-Lavoie K, Cagnon L, Diezi M, Buclin T, Widmer N, Csajka C, Decosterd L.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Apr 15;1083:124-136. doi: 10.1016/j.jchromb.2018.02.008. Epub 2018 Feb 8.

PMID:
29544202
13.

[Use of antiepileptic drugs during breastfeeding : What do we tell the mother?]

Crettenand M, Rossetti AO, Buclin T, Winterfeld U.

Nervenarzt. 2018 Aug;89(8):913-921. doi: 10.1007/s00115-018-0496-2. German.

PMID:
29487964
14.

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.

Conus P, Seidman LJ, Fournier M, Xin L, Cleusix M, Baumann PS, Ferrari C, Cousins A, Alameda L, Gholam-Rezaee M, Golay P, Jenni R, Woo TW, Keshavan MS, Eap CB, Wojcik J, Cuenod M, Buclin T, Gruetter R, Do KQ.

Schizophr Bull. 2018 Feb 15;44(2):317-327. doi: 10.1093/schbul/sbx093.

15.

Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.

Panchaud A, Rousson V, Vial T, Bernard N, Baud D, Amar E, De Santis M, Pistelli A, Dautriche A, Beau-Salinas F, Cassina M, Dunstan H, Passier A, Kaplan YC, Duman MK, Maňáková E, Eleftheriou G, Klinger G, Winterfeld U, Rothuizen LE, Buclin T, Csajka C, Hernandez-Diaz S.

Br J Clin Pharmacol. 2018 Mar;84(3):568-578. doi: 10.1111/bcp.13481. Epub 2018 Jan 14.

PMID:
29215149
16.

The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material.

Wahl P, Guidi M, Benninger E, Rönn K, Gautier E, Buclin T, Magnin JL, Livio F.

Bone Joint J. 2017 Nov;99-B(11):1537-1544. doi: 10.1302/0301-620X.99B11.BJJ-2016-0298.R3.

PMID:
29092996
17.

Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid.

Schaffer C, Buclin T, Jornayvaz FR, Cazzaniga S, Borradori L, Gilliet M, Feldmeyer L.

Dermatology. 2017;233(5):401-403. doi: 10.1159/000480498. Epub 2017 Oct 18. No abstract available.

18.

Lamotrigine serum levels: Ceiling effect in people with epilepsy in remission?

D'Anto J, Wnuk W, Rossetti AO, Decosterd LA, Buclin T, Novy J.

Epilepsy Behav. 2017 Sep;74:41-44. doi: 10.1016/j.yebeh.2017.03.031. Epub 2017 Jul 4.

PMID:
28686906
19.

Adequate plasma drug concentrations suggest that amoxicillin can be administered by continuous infusion using elastomeric pumps.

Arensdorff L, Boillat-Blanco N, Decosterd L, Buclin T, de Vallière S.

J Antimicrob Chemother. 2017 Sep 1;72(9):2613-2615. doi: 10.1093/jac/dkx178.

PMID:
28605490
20.

Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.

Marzolini C, Decosterd L, Winterfeld U, Tissot F, Francini K, Buclin T, Livio F.

Br J Clin Pharmacol. 2017 Dec;83(12):2835-2838. doi: 10.1111/bcp.13310. Epub 2017 May 16. No abstract available.

21.

Guidance to develop individual dose recommendations for patients on chronic hemodialysis.

Gotta V, Dao K, Rodieux F, Buclin T, Livio F, Pfister M.

Expert Rev Clin Pharmacol. 2017 Jul;10(7):737-752. doi: 10.1080/17512433.2017.1323632. Epub 2017 May 22. Review.

PMID:
28447486
22.

Cascaded PID controller for anaesthesia delivery.

Simalatsar A, Guidi M, Buclin T.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:533-536. doi: 10.1109/EMBC.2016.7590757.

PMID:
28268387
23.

Renal Drug Transporters and Drug Interactions.

Ivanyuk A, Livio F, Biollaz J, Buclin T.

Clin Pharmacokinet. 2017 Aug;56(8):825-892. doi: 10.1007/s40262-017-0506-8. Review.

PMID:
28210973
24.

Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT).

Voumard R, Van Neyghem N, Cochet C, Gardiol C, Decosterd L, Buclin T, de Valliere S.

J Antimicrob Chemother. 2017 May 1;72(5):1462-1465. doi: 10.1093/jac/dkw582.

PMID:
28158637
25.

Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter.

Dao K, Chtioui H, Lu Y, Peer CJ, Figg WD, Pruijm M, Buclin T, Kissling S.

Am J Kidney Dis. 2017 Apr;69(4):553-554. doi: 10.1053/j.ajkd.2016.10.026. Epub 2017 Jan 4. No abstract available.

PMID:
28063733
26.

Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure.

Dao K, Lu Y, Peer CJ, Figg WD, Stadelmann R, Burnier M, Buclin T, Kissling S.

Cancer Chemother Pharmacol. 2017 Jan;79(1):215-218. doi: 10.1007/s00280-016-3219-z. Epub 2016 Dec 17.

PMID:
27988790
27.

Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.

Aouri M, Barcelo C, Guidi M, Rotger M, Cavassini M, Hizrel C, Buclin T, Decosterd LA, Csajka C; Swiss HIV Cohort Study.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e00899-16. doi: 10.1128/AAC.00899-16. Print 2017 Jan.

28.

Biases affecting injected doses of an experimental drug during clinical trials.

Perrottet N, Brunner-Ferber F, Grouzmann E, Spertini F, Biollaz J, Buclin T, Widmer N.

Trials. 2016 Jul 16;17(1):321. doi: 10.1186/s13063-016-1463-5.

29.

Gentamicin Exposure and Sensorineural Hearing Loss in Preterm Infants.

Fuchs A, Zimmermann L, Bickle Graz M, Cherpillod J, Tolsa JF, Buclin T, Giannoni E.

PLoS One. 2016 Jul 8;11(7):e0158806. doi: 10.1371/journal.pone.0158806. eCollection 2016.

30.

Pregnancy outcome following maternal exposure to pregabalin may call for concern.

Winterfeld U, Merlob P, Baud D, Rousson V, Panchaud A, Rothuizen LE, Bernard N, Vial T, Yates LM, Pistelli A, Ellfolk M, Eleftheriou G, de Vries LC, Jonville-Bera AP, Kadioglu M, Biollaz J, Buclin T.

Neurology. 2016 Jun 14;86(24):2251-7. doi: 10.1212/WNL.0000000000002767. Epub 2016 May 18.

PMID:
27194385
31.

Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.

Barceló C, Gaspar F, Aouri M, Panchaud A, Rotger M, Guidi M, Cavassini M, Buclin T, Decosterd LA, Csajka C; Swiss HIV Cohort Study.

J Antimicrob Chemother. 2016 Jul;71(7):1933-42. doi: 10.1093/jac/dkw050. Epub 2016 Mar 29.

PMID:
27029846
32.

[Pharmacovigilance update].

Dao K, Chtioui H, Rothuizen LE, Diezi L, Prod'hom S, Winterfeld U, Buclin T, Livio F.

Rev Med Suisse. 2016 Jan 13;12(500):75-9. French.

PMID:
26946710
33.

Comparison of Population Pharmacokinetics Based on Steady-State Assumption Versus Electronically Monitored Adherence to Lopinavir, Atazanavir, Efavirenz, and Etravirine: A Retrospective Study.

Fuchs A, Rotzinger A, Cavassini M, Bugnon O, Buclin T, Schneider MP, Csajka C.

Ther Drug Monit. 2016 Aug;38(4):506-15. doi: 10.1097/FTD.0000000000000297.

PMID:
26937748
34.

Multigenerational effects of the anticancer drug tamoxifen and its metabolite 4-hydroxy-tamoxifen on Daphnia pulex.

Borgatta M, Waridel P, Decosterd LA, Buclin T, Chèvre N.

Sci Total Environ. 2016 Mar 1;545-546:21-9. doi: 10.1016/j.scitotenv.2015.11.155. Epub 2015 Dec 30.

PMID:
26745289
35.

In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid.

Aouri M, Barcelo C, Ternon B, Cavassini M, Anagnostopoulos A, Yerly S, Hugues H, Vernazza P, Günthard HF, Buclin T, Telenti A, Rotger M, Decosterd LA; Swiss HIV Cohort Study.

Drug Metab Dispos. 2016 Jan;44(1):151-61. doi: 10.1124/dmd.115.065839. Epub 2015 Nov 9.

36.

Pharmacokinetics in hepatic impairment: Mind the protein binding.

Chtioui H, Buclin T.

J Hepatol. 2015 Dec;63(6):1539-40. doi: 10.1016/j.jhep.2015.07.042. Epub 2015 Sep 4. No abstract available.

PMID:
26343957
37.

Therapeutic drug monitoring of targeted anticancer therapy.

Decosterd LA, Widmer N, Zaman K, Cardoso E, Buclin T, Csajka C.

Biomark Med. 2015;9(9):887-93. doi: 10.2217/bmm.15.78. Epub 2015 Sep 3. Review.

PMID:
26333311
38.

Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.

Winterfeld U, Klinger G, Panchaud A, Stephens S, Arnon J, Malm H, Te Winkel B, Clementi M, Pistelli A, Maňáková E, Eleftheriou G, Merlob P, Kaplan YC, Buclin T, Rothuizen LE.

J Clin Psychopharmacol. 2015 Jun;35(3):250-9. doi: 10.1097/JCP.0000000000000309.

PMID:
25830592
39.

The anticancer drug metabolites endoxifen and 4-hydroxy-tamoxifen induce toxic effects on Daphnia pulex in a two-generation study.

Borgatta M, Decosterd LA, Waridel P, Buclin T, Chèvre N.

Sci Total Environ. 2015 Jul 1;520:232-40. doi: 10.1016/j.scitotenv.2015.03.040. Epub 2015 Mar 25.

PMID:
25817760
40.

Label-free detection of tobramycin in serum by transmission-localized surface plasmon resonance.

Cappi G, Spiga FM, Moncada Y, Ferretti A, Beyeler M, Bianchessi M, Decosterd L, Buclin T, Guiducci C.

Anal Chem. 2015 May 19;87(10):5278-85. doi: 10.1021/acs.analchem.5b00389. Epub 2015 Apr 28.

PMID:
25811093
41.

[Pharmacovigilance update].

Fogarasi Szabo N, Diezi L, Delenclos L, Renard D, Chtioui H, Rothuizen LE, Buclin T, Livio F.

Rev Med Suisse. 2015 Jan 14;11(456-457):124-8. French.

PMID:
25799668
42.

Pediatric reference intervals for plasma free and total metanephrines established with a parametric approach: relevance to the diagnosis of neuroblastoma.

Franscini LC, Vazquez-Montes M, Buclin T, Perera R, Dunand M, Grouzmann E, Beck-Popovic M.

Pediatr Blood Cancer. 2015 Apr;62(4):587-93. doi: 10.1002/pbc.25385. Epub 2015 Jan 16.

PMID:
25597761
43.

[Dysmenorrhea: patience, pills or hot-water bottle?].

Graz B, Savoy M, Buclin T, Bonvin E.

Rev Med Suisse. 2014 Nov 26;10(452):2285-8. French.

PMID:
25562981
44.

Pharmacokinetic modelling of dialytic clearance in a case of acyclovir intoxication.

Kissling S, Fuchs A, Gobin N, Vogt B, Burnier M, Decosterd LA, Buclin T, Livio F.

Int J Antimicrob Agents. 2015 Mar;45(3):325-7. doi: 10.1016/j.ijantimicag.2014.12.001. Epub 2014 Dec 17. No abstract available.

PMID:
25561029
45.

High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate.

Mercier T, Tissot F, Gardiol C, Corti N, Wehrli S, Guidi M, Csajka C, Buclin T, Couet W, Marchetti O, Decosterd LA.

J Chromatogr A. 2014 Nov 21;1369:52-63. doi: 10.1016/j.chroma.2014.09.063. Epub 2014 Oct 2.

PMID:
25441071
46.

Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.

Gotta V, Widmer N, Decosterd LA, Chalandon Y, Heim D, Gregor M, Benz R, Leoncini-Franscini L, Baerlocher GM, Duchosal MA, Csajka C, Buclin T.

Cancer Chemother Pharmacol. 2014 Dec;74(6):1307-19. doi: 10.1007/s00280-014-2599-1. Epub 2014 Oct 9.

PMID:
25297989
47.

[New hepatitis C treatments: pharmacological considerations and potential for drug interactions].

Chtioui H, Buclin T, Moradpour D.

Rev Med Suisse. 2014 Sep 3;10(440):1600-4, 1606. French.

PMID:
25276998
48.

Perampanel: a significant liver enzyme inducer in some patients?

Novy J, Rothuizen LE, Buclin T, Rossetti AO.

Eur Neurol. 2014;72(3-4):213-6. doi: 10.1159/000362446. Epub 2014 Sep 13.

PMID:
25227593
49.

Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: case report, pharmacokinetic modeling, and review of the literature.

Mani LY, Kissling S, Viceic D, Vogt B, Burnier M, Buclin T, Renard D.

Hemodial Int. 2015 Apr;19(2):333-43. doi: 10.1111/hdi.12198. Epub 2014 Jul 23. Review.

PMID:
25052578
50.

Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.

Fuchs A, Guidi M, Giannoni E, Werner D, Buclin T, Widmer N, Csajka C.

Br J Clin Pharmacol. 2014 Nov;78(5):1090-101. doi: 10.1111/bcp.12444.

Supplemental Content

Loading ...
Support Center